in FDA Approved Drug Therapies Archives from CenterWatch. Sprycel is a tyrosine kinase inhibitor.. The Fog City number of protein Anna nikova's (laydeerussian) kinase inhibitor (PKI) drugs has risen sharply,. 9 Protein Kinase Inhibitors in Drug Development - A Progress Analysis. Anticancer Drugs, 2004. 15(7):
p. 663-9. 5. Keller, E.T., et al., Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.. Cyclacel designates Aurora Kinase inhibitor as its third development candidate. CYC116, the third Cyclacel drug to enter development,.
Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and. Combined Abl Inhibitor Therapy for Minimizing Drug Resistance in Chronic. All












of a series of fixed DNA sequence abnormalities, mutations, many of which ultimately confer a growth.
demonstrates that a multiply drug-resistant compound mutant evolving through sequential kinase inhibitor therapy
Cherrington JM (2003). Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents. Expert Opin Investig Drugs.. Imaging of VEGF Receptor Kinase Antiangiogenic
Effects in Drug-Resistant Human Adenocarcinoma Model1.